Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Want to see NKTR full AI Analyst Report?
Nektar Therapeutics (NKTR) Ownership Overview
3.07% Insiders
11.53% Mutual Funds
40.06% Other Institutional Investors
8.03% ETFs
37.30% Public Companies and
Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 59.63% of the company’s stock is owned by Institutional Investors, 3.07% is owned by Insiders, and 37.30% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 21, 2026 | xxxxxxxxxxxxx | $29086 | |
May 21, 2026 | xxxxxxxxxxxxx | $13036 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $13140 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $30879 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $20084843 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $287800 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $19552988 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $29883353 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,743,075 | Institution | 5.16% | 119,540,084 | |
| 1,241,379 | Institution | 3.67% | 85,133,772 | |
| 814,991 | Institution | 2.41% | 55,892,083 | |
| 814,002 | Institution | 2.41% | 55,824,257 | |
| 415,335 | Institution | 1.23% | 28,483,674 | |
| 303,574 | Insider | 0.90% | 20,819,105 | |
| 290,569 | Institution | 0.86% | 19,927,222 | |
| 287,750 | Insider | 0.85% | 19,733,895 | |
| 279,150 | Institution | 0.83% | 19,144,107 | |
| 271,758 | Institution | 0.80% | 18,637,164 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,743,075 | Institution | 5.16% | 119,540,084 | |
| 814,991 | Institution | 2.41% | 55,892,083 | |
| 290,569 | Institution | 0.86% | 19,927,222 | |
| 259,149 | Institution | 0.77% | 17,772,438 | |
| 247,634 | Institution | 0.73% | 16,982,740 | |
| 104,721 | Institution | 0.31% | 7,181,766 | |
| 90,281 | Institution | 0.27% | 6,191,471 | |
| 90,000 | Institution | 0.27% | 6,172,200 | |
| 72,788 | Institution | 0.22% | 4,991,801 | |
| 39,615 | Institution | 0.12% | 2,716,797 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 855,923 | Institution | 2.53% | 61,583,660 | |
| 312,965 | Institution | 0.93% | 22,517,832 | |
| 203,365 | Institution | 0.60% | 16,008,893 | |
| 203,365 | Institution | 0.60% | 16,008,893 | |
| 203,365 | Institution | 0.60% | 16,008,893 | |
| 152,770 | Institution | 0.45% | 12,026,054 | |
| 89,348 | Institution | 0.26% | 7,033,475 | |
| 76,798 | Institution | 0.23% | 6,023,267 | |
| 72,491 | Institution | 0.21% | 5,215,727 | |
| 63,020 | Institution | 0.19% | 4,942,659 |
FAQ
Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 40.06% of the company's stock is held by institutional investors, 3.07% is held by insiders, and 37.30% is held by retail investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.06% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.30% of Nektar Therapeutics (NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (NKTR)?
Fidelity Mt. Vernon Street Trust owns the most shares of Nektar Therapeutics (NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.